RECRUITING

Vending Machine Naloxone Distribution for Your Community (VENDY)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Vending machines are an innovative strategy shown to increase access to naloxone, a medication used to reverse opioid overdose. The aim of this proposal is to study the reach of a community-initiated, stakeholder engaged adaptation of naloxone distribution, VEnding machine Naloxone Distribution for Your community (VENDY) program.

Official Title

Vending Machine Naloxone Distribution for Your Community (VENDY): Increasing Reach and Implementation of Naloxone Distribution

Quick Facts

Study Start:2024-06-01
Study Completion:2026-01-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06429436

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Any person in the community who desires to obtain naloxone will be able to use the machines
  1. * Inability to enter a code on a vending machine or open a kiosk.

Contacts and Locations

Study Contact

Nicole Wagner, PhD
CONTACT
(303)724-7095
nicole.wagner@cuanschutz.edu
Meagan R Bean, MPH
CONTACT
(303)724-7095
meagan.bean@cuanschutz.edu

Principal Investigator

Nicole Wagner, PhD
PRINCIPAL_INVESTIGATOR
University of Colorado - Anschutz Medical Campus

Study Locations (Sites)

Denver Health
Denver, Colorado, 80204
United States
Summit County Public Health Department
Frisco, Colorado, 80443
United States
Southern Colorado Harm Reduction Association
Pueblo, Colorado, 81004
United States

Collaborators and Investigators

Sponsor: University of Colorado, Denver

  • Nicole Wagner, PhD, PRINCIPAL_INVESTIGATOR, University of Colorado - Anschutz Medical Campus

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-06-01
Study Completion Date2026-01-01

Study Record Updates

Study Start Date2024-06-01
Study Completion Date2026-01-01

Terms related to this study

Additional Relevant MeSH Terms

  • Harm Reduction
  • Naloxone
  • Opioid Overdose